XTX Topco Ltd Takes $5.96 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

XTX Topco Ltd bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 12,027 shares of the medical equipment provider’s stock, valued at approximately $5,957,000. Intuitive Surgical comprises 0.3% of XTX Topco Ltd’s investment portfolio, making the stock its 27th largest holding.

Several other hedge funds have also modified their holdings of the stock. Chilton Capital Management LLC lifted its stake in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares in the last quarter. Parvin Asset Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth about $26,000. Global Financial Private Client LLC lifted its stake in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 38 shares in the last quarter. Elite Financial Inc. purchased a new stake in Intuitive Surgical in the 1st quarter worth about $26,000. Finally, Hurley Capital LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Down 0.4%

Shares of NASDAQ:ISRG opened at $493.95 on Tuesday. The business has a 50 day moving average price of $528.51 and a 200 day moving average price of $534.63. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market cap of $177.07 billion, a price-to-earnings ratio of 68.89, a PEG ratio of 5.20 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the company earned $1.78 EPS. The firm’s revenue for the quarter was up 21.4% compared to the same quarter last year. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director owned 6,371 shares in the company, valued at $3,312,920. This represents a 27.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,610 shares of company stock worth $3,858,340 in the last 90 days. 0.70% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on ISRG shares. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a “hold” rating to a “sell” rating and reduced their price objective for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Evercore ISI upped their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 8th. BTIG Research upped their target price on Intuitive Surgical from $566.00 to $571.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Finally, Robert W. Baird dropped their target price on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $592.05.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.